- AU$142.54m
- AU$102.18m
- AU$103.51m
- 67
- 89
- 79
- 90
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.03 | ||
| PEG Ratio (f) | 0.45 | ||
| EPS Growth (f) | 21.97% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.15 | ||
| Price to Tang. Book | 2.3 | ||
| Price to Free Cashflow | 1.3 | ||
| Price to Sales | 0.76 | ||
| EV to EBITDA | 8.61 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.81% | ||
| Return on Equity | 8.37% | ||
| Operating Margin | 6.03% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 30.25 | 106.56 | 63.49 | 83.4 | 103.5 | 359.4 | 394.1 | 33.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +68.89 | +38.85 | -18.82 | -45.11 | +123.92 | +105.95 | +12.3 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NobleOak Life Limited is an Australia-based company that provides life insurance products. The Company is principally engaged in manufacturing and distributing life insurance products, including death, disability, trauma, income protection, and business expenses insurance. The Company segments include Direct Business, Partnership, and Genus. The Direct Business segment consists of the life insurance protection products that are sold directly to customers under the NobleOak brand. The Partnership segment consists of life insurance protection products, which are sold to customers primarily through advisors under the Company's partner brands. The Genus segment consists of life insurance administration services performed by the NobleOak Group Company, Genus Life Insurance Services Pty Ltd. The Company also provides administration services for run-off life insurance products through its subsidiary Genus Life Insurance Services Limited.
Directors
- Stephen Harrison NEC
- Anthony Brown CEO
- Scott Pearson CFO
- Charisse Nortje SEC
- Sarah Brennan DRC (54)
- Andrew Boldeman NED
- Kevin Hamman NID
- Inese Kingsmill NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 5th, 1902
- Public Since
- July 22nd, 2021
- No. of Shareholders
- 2,175
- Sector
- Insurance
- Industry
- Financials
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 86,385,174
- Address
- Level 4/44 Market St, SYDNEY, 2000
- Web
- https://www.nobleoak.com.au/
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for NOL
Similar to NOL
AUB
Australian Stock Exchange - SEATS
Challenger
Australian Stock Exchange - SEATS
Clearview Wealth
Australian Stock Exchange - SEATS
Helia
Australian Stock Exchange - SEATS
Insurance Australia
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:15 UTC, shares in NobleOak Life are trading at AU$1.65. This share price information is delayed by 15 minutes.
Shares in NobleOak Life last closed at AU$1.65 and the price had moved by -2.37% over the past 365 days. In terms of relative price strength the NobleOak Life share price has underperformed the ASX All Ordinaries Index by -6.61% over the past year.
The overall consensus recommendation for NobleOak Life is Buy. You can view the full broker recommendation list by unlocking its StockReport.
NobleOak Life does not currently pay a dividend.
NobleOak Life does not currently pay a dividend.
NobleOak Life does not currently pay a dividend.
To buy shares in NobleOak Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$1.65, shares in NobleOak Life had a market capitalisation of AU$142.54m.
Here are the trading details for NobleOak Life:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NOL
Based on an overall assessment of its quality, value and momentum NobleOak Life is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in NobleOak Life is AU$2.80. That is 69.52% above the last closing price of AU$1.65.
Analysts covering NobleOak Life currently have a consensus Earnings Per Share (EPS) forecast of AU$0.19 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NobleOak Life. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -16.09%.
As of the last closing price of AU$1.65, shares in NobleOak Life were trading -1.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NobleOak Life PE ratio based on its reported earnings over the past 12 months is 8.03. The shares last closed at AU$1.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NobleOak Life's management team is headed by:
- Stephen Harrison - NEC
- Anthony Brown - CEO
- Scott Pearson - CFO
- Charisse Nortje - SEC
- Sarah Brennan - DRC
- Andrew Boldeman - NED
- Kevin Hamman - NID
- Inese Kingsmill - NID